MolGraphRequest Quote
CAS 138199-71-0Preliminary Safety ReferenceNot a supplier-issued SDSSupplier SDS by request

CAS 138199-71-0 Safety Reference and Supplier SDS Request

Levofloxacin Hydrate

Back to CAS detail

Preliminary reference disclaimer

This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.

Documentation status

Preliminary safety reference

Available

Supplier-issued SDS

Available by request

COA

Available by RFQ / lot confirmation

Transport classification

Requires shipment review

Identity

CAS Number

138199-71-0

Chemical name

Levofloxacin Hydrate

Molecular formula

C36H42F2N6O9

Molecular weight

740.7 g/mol

Synonyms

(3S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid hemihydrate; Dynaquin; Levofloxacin (hydrate); (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrate(2:1); 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (3S)-; Levaquin (TN); (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hemihydrate; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-hydrate (2:1), (S)-; Levofloxacin [USAN]; RWJ 25213; Levofloxacin (USP); Quixin (TN)

InChIKey

SUIQUYDRLGGZOL-RCWTXCDDSA-N

PubChem CID

3033924

Hazard / GHS Reference

Signal word

Danger

Catalog reference cue; confirm supplier documentation before use.

Hazard statements

H302, H317, H334, H361, H362

Catalog reference cue; confirm supplier documentation before use.

Handling & PPE

  • Keep container tightly closed and dry. Store in a well-ventilated place. Recommended storage conditions: pressurized, room temperature
  • Avoid contact with skin and eyes. Avoid generating dust and aerosols. Provide suitable ventilation equipment in areas where dust is generated. General fire protection measures.
  • Use a P95 (US) or P1 (EU UK 143) particulate respirator if exposed to harmful environments. For higher level of protection, use OV/AG/P99 (US) or ABEK-P2 (EU UK 143) gas cartridges. Respirators must be tested and approved by government standards such as NIOSH (US) or CEN (EU).

First Aid / Accidental Release

  • If inhaled, move the patient to fresh air. If breathing stops, perform artificial respiration. Consult a physician.
  • Rinse with plenty of water for at least 15 minutes and consult a physician.
  • Wash with soap and plenty of water. Consult a physician.
  • Do not generate dust when collecting and disposing. Sweep and shovel. Place in a suitable closed container for disposal.
  • Use personal protective equipment and emergency procedures. Avoid dust generation. Avoid inhaling vapors, mists or gases. Ensure adequate ventilation. Evacuate personnel to a safe area. Avoid inhaling dust. See
  • Do not allow the product to enter drains.

Firefighting / Stability

  • Wear self-contained breathing apparatus if necessary.
  • Reactivity
  • Carbon monoxide, carbon dioxide, hydrogen fluoride, nitrogen oxides

Physical and Chemical Reference

Physical property reference values are not available in the current MolGraph catalog record.

Transport / Shipment Review

Shipment review

Shipment details require review before fulfillment.

Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.

  • Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.